Lansoprazole | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lansoprazole
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Lansoprazole

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

101 API Suppliers, 39 USDMF, 26 CEP/COS, 18 JDMF, 21 EU WC, 18 KDMF, 21 NDC API, 55 Listed Suppliers, $ API Reference Price

101 API Suppliers
39 USDMF
26 CEP/COS
18 JDMF
21 EU WC
18 KDMF
21 NDC API
55 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

23 Intermediates Suppliers

23 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

742 FDF Dossiers, 68 FDA Orange Book, 462 Europe, 27 Canada, 37 Australia, 37 South Africa, 111 Listed Dossiers

742 FDF Dossiers
68 FDA Orange Book
462 Europe
27 Canada
37 Australia
37 South Africa
111 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 30MG, CAPSULE, DELAYED REL PELLETS;ORAL - 15MG, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 30MG
CAPSULE, DELAYED REL PELLETS;ORAL - 15MG
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 8 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 11 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 2 Clariant, 14 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

98 Fillers, Diluents & Binders, 74 Coating Systems & Additives, 44 Thickeners and Stabilizers, 43 Direct Compression, 41 Controlled & Modified Release, 38 Taste Masking, 32 Solubilizers, 29 Film Formers & Plasticizers, 24 Lubricants & Glidants, 24 Granulation, 23 Topical, 23 Parenteral, 23 Disintegrants & Superdisintegrants, 21 Chewable & Orodispersible Aids, 21 Co-Processed Excipients, 12 Emulsifying Agents, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

98 Fillers, Diluents & Binders
74 Coating Systems & Additives
44 Thickeners and Stabilizers
43 Direct Compression
41 Controlled & Modified Release
38 Taste Masking
32 Solubilizers
29 Film Formers & Plasticizers
24 Lubricants & Glidants
24 Granulation
23 Topical
23 Parenteral
23 Disintegrants & Superdisintegrants
21 Chewable & Orodispersible Aids
21 Co-Processed Excipients
12 Emulsifying Agents
9 Empty Capsules
8 Surfactant & Foaming Agents
8 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 197 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
197 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 408 Finished Drug Prices, 3 Annual Reports

2 US Medicaid Prescriptions
408 Finished Drug Prices
3 Annual Reports

MARKET PLACE

18 APIs, 10 FDF Dossiers

18 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 27 Health Canada Patents

2 US Patents
27 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 15 Others

2 EDQM
1 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

1 BioAnalytical Methods
4 Analytical Methods

$ API Ref.Price (USD/KG) : 93 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2DEXCEL

filter Patent Number Reset all filters

2 All

01 111077055

02 111986554

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22036-04-21

Product Main Page

01

DEXCEL

Pharma, Lab & Chemical Expo

Not Confirmed

DEXCEL

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-04-21

LANSOPRAZOLE

US Patent Number : 11077055

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208025

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

DEXCEL

Pharma, Lab & Chemical Expo

Not Confirmed

DEXCEL

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-04-21

LANSOPRAZOLE

US Patent Number : 11986554

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208025

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?